Product Usage: This product is intended solely for use as a research chemical. It is designated exclusively for in vitro research and laboratory testing. All information provided on this site is for educational purposes only. It is strictly prohibited to administer this product to humans or animals. Only licensed and qualified professionals should handle it. This product is not classified as a drug, food, or cosmetic and must not be misrepresented or used as such. This product is for research use only. Not for human consumption.
CJC1295 + Ipamorelin 10 mg
This 10mg peptide blend contains CJC-1295 (No DAC) and Ipamorelin, each at 5mg, designed to synergistically enhance natural growth hormone (GH) secretion through complementary mechanisms.
CJC-1295 (No DAC) stimulates the body’s growth hormone-releasing hormone (GHRH) receptors, promoting a natural, rhythmic release of GH. It’s being studied for its ability to support muscle recovery, fat metabolism, and overall regenerative function.
Ipamorelin is one of the most selective GH secretagogues and acts as a ghrelin receptor agonist. Research shows it may help improve bone density, muscle regeneration, pancreatic insulin secretion, and gastrointestinal motility, all with minimal impact on cortisol or prolactin levels.
When used together, CJC-1295 and Ipamorelin have demonstrated synergistic potential, offering a more potent and physiologically balanced enhancement of endogenous GH levels. This combination is of interest in studies related to anti-aging, tissue repair, and overall metabolic optimization.
$90.00
Cellular Age Support Peptides
Cellular Growth Research Peptides
Metabolic Activation Peptides
Metabolic Research Peptides
Popular Peptides
Reproductive System Research Peptides
Tissue Integrity Research Peptides
Uncategorized
- DESCRIPTION
- STORAGE
Ipamorelin and CJC-1295 Overview
Ipamorelin is a synthetic peptide that has been characterized in preclinical research as a highly selective growth hormone (GH) secretagogue and agonist of the ghrelin / growth hormone secretagogue receptor (GHSR). In animal and in-vitro studies, ipamorelin has been evaluated for its potential roles in skeletal and connective tissue, skeletal muscle biology, pancreatic signaling, and gastrointestinal motility and coordination.
CJC-1295 is a synthetic analogue of growth hormone releasing hormone (GHRH) that interacts with the GHRH receptor in the anterior pituitary. It has been investigated in research models for its ability to influence physiological GH pulse patterns and for its potential effects on bone parameters, body composition, insulin-related pathways, and muscle tissue characteristics.
Because ipamorelin and CJC-1295 act at different points in the GH axis (GHSR versus GHRH receptor), researchers are exploring combination protocols in controlled animal studies. In theory, ipamorelin may help shape baseline GH signaling, while CJC-1295 modulates pulsatile release. This dual-pathway approach is of interest for examining how changes in GH dynamics could correlate with experimental readouts such as lean mass, tissue repair markers, glucose handling, and other metabolic endpoints in non-clinical models.
Research Use Only
The information above is provided for scientific and educational purposes only. Ipamorelin and CJC-1295 are not approved medicines or drugs and have not been evaluated by the FDA or any other regulatory agency to diagnose, treat, cure, or prevent any disease or medical condition. These compounds are supplied solely for in-vitro and other approved laboratory research applications and are not intended for human or animal
administration in any form.
Factor Peptides Storage Guidelines:
These peptides arrive in a dried, stabilized form produced by a process called lyophilization, or freeze drying. In this state, they are generally suitable for transport and short-term storage at typical room temperatures for several months.
Once the dry powder is mixed with bacteriostatic water and turned into a liquid solution, the storage requirements change. The reconstituted solution should be kept in a refrigerator to help maintain its properties, and is usually considered suitable for use for about 30 days under chilled conditions.
Lyophilization involves freezing the material and then exposing it to low pressure so that ice in the sample passes directly from solid to vapor, rather than melting. This leaves behind a light, porous, white solid that is more stable than the original liquid. In this form, the product can often be kept at room temperature until it is time to add diluent.
After delivery, it is good practice to protect the vials from heat and strong light. If the product will be used in the near future, storing the lyophilized powder or reconstituted solution in a refrigerator at temperatures below about 4°C (39°F) is typically appropriate. The dry form often remains intact at room temperature for a number of weeks, so this may also be acceptable when immediate refrigeration is not available and the intended use is relatively soon.
For storage over longer periods, such as many months or years, much colder conditions are preferred. Placing the vials in a deep freezer, around -80°C (-112°F), is commonly used to help preserve the structure and activity of peptides for extended time frames.